The saddest part of the $CHMA story is the FDA had plenty of time before the company wasted time and money to get to do a trial that the FDA approved prior. Now one could argue the company and Roche should have been smart enough to run a control arm.
Anyway was a great trade Sheff, as you know I was short a few shares (posted on twitter) going into the binary event.
Market Data 
Markets 
AI
